Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a reference TPS dose with the calculated dose in 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.:

NIAID Data Ecosystem60

Subgroup analyses of the risk of ICS use on study outcomes.

药物安全性评估

呼吸系统疾病治疗

Subgroup analyses of the risk of ICS use on study outcomes.

NIAID Data Ecosystem20

Data from: Quantifying post- laser ablation prostate therapy changes on MRI via a domain-specific biomechanical model: preliminary findings

医学影像分析

前列腺癌治疗

Focal laser ablation destroys cancerous cells via thermal destruction of tissue by a laser. Heat is absorbed, causing thermal necrosis of the target region. It combines the aggressive benefits of radi

DataONE2016-05-11 更新80

fdata-02-00047_Human Cell-Based in vitro Phenotypic Profiling for Drug Safety-Related Attrition.pdf

药物安全性评估

毒性测试

Ensuring the safety of new drugs is critically important to regulators, pharmaceutical researchers and patients alike. Even so, unexpected toxicities still account for 20–30% of clinical trial failure

NIAID Data Ecosystem30

Profile of adverse events (AE) based on initial dose of enzalutamide.

资源简介：

相关数据集